Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M. Riedl, Armin Gerger, Florian Posch et al.|Therapeutic Advances in Medical Oncology|2021Cited by 10
1938P Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trialArmin Gerger, Ellen Heitzer, Jakob M. Riedl et al.|Annals of Oncology|2020Cited by 0